releases: https://westerman.house.gov/media-center/press-releases/bipartisan-prescription-drug-pricing-bill-reintroduced-house
Data license: MIT · Data source: dwillis/congress-press
This data as json
| url | title | date | year | month | party | chamber | state | member_name | bioguide_id | domain | scraper | source | date_source | text | has_text | collected_at | updated_at |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| https://westerman.house.gov/media-center/press-releases/bipartisan-prescription-drug-pricing-bill-reintroduced-house | Bipartisan Prescription Drug Pricing Bill Reintroduced in House | 2022-05-20 | 2022 | 2022-05 | Republican | House | AR | Bruce Westerman | W000821 | westerman.house.gov | westerman | https://westerman.house.gov/media-center/press-releases | scraper | WASHINGTON - This week, Congressman Bruce Westerman (AR-04), Ranking Member of the House Natural Resources Committee, and Congresswoman Jan Schakowsky (IL-09), a Senior Chief Deputy Whip and Chair of the Energy and Commerce Consumer Protection and Commerce Subcommittee reintroduced the Price Relief, Innovation, and Competition for Essential Drugs (PRICED) Act to make prescription drugs more affordable and accessible for Americans across the nation. The bicameral PRICED Act, the first version of which was introduced in the Senate in 2016 by Senators Sherrod Brown (D-OH) and the late John McCain (R-AZ), addresses increasing drug prices by reducing drug manufactures’ exclusivity periods for biologics from twelve years to five years. | 1 | 2026-03-30T01:40:41Z | 2026-04-08T02:29:07Z |